Summary
Introduction
Menstrual and reproductive factors, as well as female hormones, have long been related to ovarian carcinogenesis [1, 2] . Most studies found a moderately increased risk in women with early menarche. The relative risks were approximately 1.2-1.3 in women reporting earlier menarche [3, 4] , but a quantification of the issue remains open to discussion [3] .
Several studies showed a direct relation between late age at menopause and the risk of ovarian cancer. The strength of the association, however, ranges from about 1.5 to 3.0 in women with later menopause [1] , and needs therefore quantification.
Nulliparity and low parity have been consistently related to ovarian cancer risk. Several investigations showed also a decline in risk associated with full term pregnancies beyond the first, thus suggesting that additional risk reduction was conferred by events accompanying each pregnancy [5, 6] .
The protection conferred by combined oral contraceptives (OCs) against subsequent ovarian cancer risk is one of the best established and most important features of ovarian cancer epidemiology [1, [7] [8] [9] [10] on a public health scale. The favourable effect of OCs against ovarian cancer risk seems to persist for at least 10-15 years after stopping use [7] .
With reference to hormone replacement therapy (HRT) in menopause, some studies reported moderately elevated risks, and others no consistent association [8] . Garg et al. [11] , in a meta-analysis, reported an odds ratio (OR) of 1.15 for ever users. Coughlin et al. [12] in a subgroup analysis of four case-control studies from the US, found a borderline association between HRT and ovarian cancer (OR = 1.3). Negri et al., in a metaanalysis of four European studies, found an OR of 1.7 for ever HRT users [13] .
An increased risk of ovarian cancer has been reported in women with a family history of ovarian and breast cancer, but again quantification of the issue in various populations is important [1, 14, 15] .
We have considered data on these issues from a uniquely large, multicentric case-control study from Italy.
Patients and methods
The data were derived from a case-control study of ovarian cancer, conducted between January 1992 and September 1999 in four Italian areas: greater Milan, the provinces of Pordenone, Padua and Gorizia (northern Italy); the province of Latina (central Italy); the urban area of Naples (southern Italy). The interviewers were centrally trained. Less than 4% of cases and controls approached refused the interview, and the response rates did not vary across hospitals and geographic areas. Cases were 1031 women (median age 56, range 18-79 years) with incident (i.e., diagnosed within the year before interview), histologically confirmed ovarian cancer, admitted to the major teaching and general hospitals in the areas under surveillance.
Controls were 2411 women (median age 57, range 17-79 years) residing in the same geographical areas and admitted to the same network of hospitals as cases for a wide spectrum of acute, nonneoplastic conditions, unrelated to known or likely risk factors for ovarian cancer. Women were specifically excluded if admitted for hormonal and gynaecological diseases, and if they had been ovariectomized. Among controls, 26% had traumatic conditions (mostly fractures and sprains), 28% non-traumatic orthopedic disorders (mostly low back pain and disc disorders), 15% acute surgical conditions (mostly abdominal, such as acute appendicitis or strangulated hernia), and 31% miscellaneous other illnesses (such as eye, ear, nose, throat and dental disorders).
All interviews were conducted in hospital using a structured questionnaire, including information on age, education and other socioeconomic factors, anthropometric variables, smoking habits, alcohol intake, coffee consumption, a validated food frequency section, a problem-oriented medical history, history of cancer in first degree relatives, gynecological and obstretric data. Information was specifically obtained on age at menarche, menstrual cycle pattern, type and age at menopause, number of births, spontaneous and induced abortions, age at each pregnancy and birth, and lactation. Data were also elicited on history of lifelong use of OCs and HRT, including time and duration of each episode of use.
Data analysis
Odds ratios (OR) of ovarian cancer, and the corresponding 95% confidence intervals (Cl), were derived using unconditional multiple logistic regression, fitted by the method of maximum likelihood [16] . Two models were considered: the first one including terms for age and center; the second further terms for education, parity, oral contraceptive (OC) use, and family history of ovarian/breast cancer in first degree relatives.
Results
The distribution of cases and controls, and the corresponding ORs, according to age and selected variables is presented in Table 1 . The risk of ovarian cancer was higher among women reporting 12 or more years of education (OR 1.9, 95% CI: 1.5-2.4), in comparison with less educated ones. No association emerged between marital status, body mass index and ovarian cancer. An increased risk emerged in women with a family history of breast and/or ovarian cancer: the OR was 2.6 (95% CI: 2.0-3.5) for those reporting one or more first degree relatives with breast and/or ovarian cancer, in comparison with women with no such history.
The relation between menstrual factors and ovarian cancer is considered in Table 2 : in comparison with women reporting menarche at age ^ 12 years, the OR was 0.8 (95% CI: 0.6-1.0) in women with menarche at 3= 15 years. Among post-menopausal women, the multivariate OR was 0.6 (95% CI: 0.5-0.9) for women aged at menopause < 45 years compared with women with later menopause. There was no relation between menstrual cycle duration and pattern and ovarian cancer risk. " In some cases the sum does not add up to the total because of missing values. b Odds ratios from multiple logistic regression including terms for age and center. c Odds ratios from multiple logistic regression including further terms for education, parity, OC use, and family history of ovarian and breast cancer in first degree relatives. d Reference category. " Nulliparous women excluded. Table 3 considers the relation between ovarian cancer and reproductive history. In comparison with nulliparae, the multivariate ORs were not below unity for women with one or two births, but declined to 0.6 (95% CI: 0.5-0.9) for women reporting three births and 0.5 (95% CI: 0.3-0.7) for those reporting > four births. Spontaneous and induced abortions were not associated with the risk of ovarian cancer, but absolute numbers of women reporting ^ 2 abortions were small. With reference to age at first birth, the risk of ovarian cancer was elevated in women who bore their first child at age 25-29 years (OR = 1.4) and 30 or more (OR = 1.5), and both ORs were of borderline statistical significance, when compared to women who bore their first child at age 20 or less. No clear relation emerged between time since last birth, breast feeding, and ovarian cancer.
The relation between OC and HRTand ovarian cancer risk is considered in Table 4 . The OR for ever versus never OC users was 0.9, but the OR declined to 0.5 (95% CI: 0.3-0.9) in women reporting OC use for 60 months or more. Among these, the OR was 0.5 (0.2-1.2) for women who had stopped since ^ 10 years. In contrast, the risk of ovarian cancer was directly related to HRT use: the .7) 269(11.2) OR was 1.4 in women reporting HRT use for 25 months or more, but the estimate was not significant. Table 5 presents the ORs of ovarian cancer for parity, duration of OC use and age at menopause in separate strata of history of ovarian and/or breast cancer in first degree relatives. The pattern of risk was similar in the two strata of parity and age at menopause, but the risk for ever OC use was not below unity among women with positive family history. The estimate, however, was based on five cases and five controls only, and no significant heterogeneity was evident.
Discussion
The present study confirms and further quantifies that multiparity is associated with a significant reduction of ovarian cancer risk. Likewise, late age at menarche and early menopause appear to confer some protection. Our data also confirm the well known protection of OCs on ovarian carcinogenesis, with a 50% decrease for women who had used OCs for five years or longer, which is consistent with most available information on this issue [1, [7] [8] [9] [10] . Such a decreased risk persisted for at least 10 years after stopping use. However, no risk reduction was evident for shorter use. The inconsistent pattern of risk with duration may be explained by the low prevalence of OC use in the Italian population in the past [17] , and consequently by the imprecision of each single estimate.
Our data also provide further support for a moderate association between long-term use of HRT and ovarian cancer [8, [11] [12] [13] , although the estimate was not statistically significant, possibly again on account of low prevalence of HRT use in Italy [18] , and hence to the small absolute numbers. Family history of ovarian/breast cancer increases the risk of ovarian cancer [1, 15] , and it is therefore important to better understand the combined role of environmental and hormonal factors in ovarian carcinogenesis [15, 19] . In our study, multiparity reduced the risk of ovarian cancer in women with a positive family history to the level seen in multiparous women whose family history was negative. It thus appears that parity has an indipendent contribution in determining the risk of ovarian cancer, thus confirming the results of another large Italian study [19] . The findings are, however, less clear for OCs and age at menopause, possibly on account of small absolute numbers in women with positive family history, despite the uniquely large dataset available.
With reference to potential limitations and strengths of this study, hospital controls are preferable for several aspects in the analysis of reproductive factors, since parity may influence response rates in population controls [20] . With regard to other possible sources of selection bias, the catchment areas of cases and controls were comparable, and participation was almost complete. Furthermore, we excluded from the control group women admitted to the hospital for any neoplastic, gynaecological and hormone-related conditions. It is unlikely that information on parity or age at births is appreciably biased. With further reference to possible information bias, specific attention was paid to collect the history of OC and HRT use in a standardized way, and selfreported OC and HRT history has been shown satisfactorily valid [21, 22] . With reference to confounding, this study confirmed that ovarian cancer is directly related to social class indicators [1] , but allowance for education was made in all the analyses. Most risk factors, moreover, were similar after allowance for age only or for a large number of potential confounding or modifying factors, indicating that residual confounding from major identified covariates is unlikely.
The incessant ovulation [1, 23, 24] , and the gonadotropin hypotheses [25, 26] have been proposed to explain the role of hormonal and reproductive factors in the etiology of epithelial ovarian cancer. The protective effect conferred by parity and OCs would suggest an unfavourable role of ovulation on epithelial ovarian cancer, but the limited effect of age at menarche and at menopause, as well as the possible influence of age at births, cannot be totally explained by ovulation [2, 24, 27] . The lack of protection from HRT (which suppresses pituitary hormones) does not support the existence of a favourable role of gonadotropin stimulation on ovarian carcinogenesis [8] . A more complex mechanism of carcinogenesis is consequently likely to be involved in the etiology of epithelial ovarian cancer [2] .
